SINTA - Science and Technology Index

BAYU ARDIANSAH

Universitas Indonesia S1 - Kimia SINTA ID : 6028146

Synthetic Organic Chemistry

1.083

SINTA Score Overall

150

SINTA Score 3Yr

1.083

Affil Score

150

Affil Score 3Yr

Latest number of activities

MOLECULAR HYBRID OF BENZIMIDAZOLE-1,2,3-TRIAZOLE TETHERED UNSYMMETRICAL CURCUMIN ANALOGS: SYNTHESIS AND BIOLOGICAL EVALUATION AS ANTIOXIDANT, ANTIMICROBIAL, AND ANTICANCER COMPOUNDS

Leader : Bayu Ardiansah KOMPETITIF ( PUTI Q1 2024 )

Personils : -

2024 Rp. 150,000,000.00 Approved

PREPARASI NANOPARTIKEL FEMNO3 DENGAN METODE SINTESIS HIJAU MENGGUNAKAN EKSTRAK DAUN RAMBUTAN DAN POTENSINYA SEBAGAI KATALIS REAKSI KONDENSASI ALDOL

Leader : Bayu Ardiansah KOMPETITIF ( PUTI Q1 2024 )

Personils : -

2024 Rp. 150,000,000.00 Approved

DESIGN, SYNTHESIS, ANTIMICROBIAL AND ANTICANCER INVESTIGATION OF ISATIN DERIVATIVES CONTAINING TRIAZOLE-HYDRAZONE HYBRID

Leader : Bayu Ardiansah KOMPETITIF ( PUTI Q1 2024 )

Personils : -

2024 Rp. 150,000,000.00 Approved

ZAT ANTI-TUBERKULOSIS DARI LIMBAH PERIKANAN: MODIFIKASI KANDUNGAN ASAM LEMAK MENJADI ESTER 1,2,3-TRIAZOLA

Leader : Bayu Ardiansah INOVASI ( RIIM )

Personils : -

2024 Rp. 81,000,000.00 Approved

PEMANFAATAN SENYAWA FENOLIK ZINGERONE UNTUK SINTESIS PRODUK BERBASIS N, O, DAN S-HETEROSIKLIK SEBAGAI ZAT ANTI RADIKAL BEBAS

Leader : Bayu Ardiansah KOMPETITIF ( PUTI Q1 2022 )

Personils : -

2023 Rp. 120,000,000.00 Approved

MODIFIKASI SENYAWA BAHAN ALAM SINAMALDEHIDA MELALUI REAKSI KONDENSASI ALDOL BERBASIS SIKLIK TRIAZOL SEBAGAI KANDIDAT OBAT ANTIDIABETES

Leader : Bayu Ardiansah KOMPETITIF ( PUTI Q2 2022 )

Personils : -

2023 Rp. 100,000,000.00 Approved

SYNTHESIS, BIOLOGICAL EVALUATION, AND COMPUTATIONAL STUDIES OF UNSYMMETRICAL CURCUMIN ANALOGUES BEARING 1,2,3-TRIAZOLE MOTIF

Leader : Bayu Ardiansah PUTI Q1 2023 ( PUTI Q1 2023 )

Personils : -

2023 Rp. 150,000,000.00 Approved

SYNTHESIS OF CHALCONE-CITRONELLOL HYBRIDS WITH 1,2,3-TRIAZOLE LINKER AND EVALUATION OF THEIR ANTIDIABETIC POTENTIAL

Leader : Bayu Ardiansah PUTI Q1 2023 ( PUTI Q1 2023 )

Personils : -

2023 Rp. 150,000,000.00 Approved

SYNTHESIS, ANTIHYPERGLYCEMIC EVALUATION, AND MOLECULAR DOCKING ANALYSIS OF NOVEL SERIES OF CHALCONE DERIVATIVES INTEGRATED WITH N-HETEROCYCLE

Leader : Bayu Ardiansah PUTI Q2 2023 ( PUTI Q2 2023 )

Personils : -

2023 Rp. 100,000,000.00 Approved

MODIFIKASI SENYAWA BAHAN ALAM SINAMALDEHIDA MELALUI REAKSI KONDENSASI ALDOL BERBASIS SIKLIK TRIAZOL SEBAGAI KANDIDAT OBAT ANTIDIABETES

Leader : Bayu Ardiansah KOMPETITIF ( PUTI Q2 2022 )

Personils : -

2022 Rp. 85,000,000.00 Approved

	Scopus	GScholar	WOS
Article	44	60	0
Citation	196	244	0
Cited Document	34	39	0
H-Index	8	9
i10-Index	7	7
G-Index	1	1

BAYU ARDIANSAH

Summary